AVIR Green Hills Biotechnology AG
5 clinical trials · Sponsor
◉ Watch AVIR Green Hills Biotechnology AG
| Record | Firm | Date |
|---|---|---|
| Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults (NCT01369862) | AVIR Green Hills Biotechnology AG | 2011-01-01 |
| Dose Finding Study of Single Dose GHB11L1 in Healthy Adults (NCT01078701) | AVIR Green Hills Biotechnology AG | 2009-12-01 |
| Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults (NCT03745274) | AVIR Green Hills Biotechnology AG | 2008-12-19 |
| Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults (NCT00741806) | AVIR Green Hills Biotechnology AG | 2008-08-01 |
| Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers (NCT00724997) | AVIR Green Hills Biotechnology AG | 2007-03-01 |
Track AVIR Green Hills Biotechnology AG automatically
Every clearance here is in the API, with alerts when new ones post.